FDP
REGN icon

Financiere des Professionnels’s Regeneron Pharmaceuticals REGN Stock Holding History

Financiere des Professionnels’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Hold
3,171
– – 0.11% 150
2026
Q1 		$2.45M Hold
3,171
– – 0.14% 134
2025
Q4 		$2.45M Hold
3,171
– – 0.14% 132
2025
Q3 		$1.78M Buy
+3,171
New +$1.79M 0.1% 140

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Financiere des Professionnels's REGN Position: Q2 2026 in Review

Financiere des Professionnels held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 3,171 shares worth $1.98M. The position accounts for 0.11% of the portfolio, ranked #150.

Financiere des Professionnels first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.45M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Financiere des Professionnels held 3,171 shares of Regeneron Pharmaceuticals worth $1.98M as of Q2 2026.
  • Financiere des Professionnels left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.11% of Financiere des Professionnels's portfolio in Q2 2026, its #150 holding.
  • Financiere des Professionnels first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Financiere des Professionnels's Regeneron Pharmaceuticals position peaked at $2.45M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.